Literature DB >> 34499540

Disparities in Opioid Overdose Death Trends by Race/Ethnicity, 2018-2019, From the HEALing Communities Study.

Marc R Larochelle1, Svetla Slavova1, Elisabeth D Root1, Daniel J Feaster1, Patrick J Ward1, Sabrina C Selk1, Charles Knott1, Jennifer Villani1, Jeffrey H Samet1.   

Abstract

Objectives. To examine trends in opioid overdose deaths by race/ethnicity from 2018 to 2019 across 67 HEALing Communities Study (HCS) communities in Kentucky, New York, Massachusetts, and Ohio. Methods. We used state death certificate records to calculate opioid overdose death rates per 100 000 adult residents of the 67 HCS communities for 2018 and 2019. We used Poisson regression to calculate the ratio of 2019 to 2018 rates. We compared changes by race/ethnicity by calculating a ratio of rate ratios (RRR) for each racial/ethnic group compared with non-Hispanic White individuals. Results. Opioid overdose death rates were 38.3 and 39.5 per 100 000 for 2018 and 2019, respectively, without a significant change from 2018 to 2019 (rate ratio = 1.03; 95% confidence interval [CI] = 0.98, 1.08). We estimated a 40% increase in opioid overdose death rate for non-Hispanic Black individuals (RRR = 1.40; 95% CI = 1.22, 1.62) relative to non-Hispanic White individuals but no change among other race/ethnicities. Conclusions. Overall opioid overdose death rates have leveled off but have increased among non-Hispanic Black individuals. Public Health Implications. An antiracist public health approach is needed to address the crisis of opioid-related harms. (Am J Public Health. 2021;111(10):1851-1854. https://doi.org/10.2105/AJPH.2021.306431).

Entities:  

Mesh:

Year:  2021        PMID: 34499540      PMCID: PMC8561170          DOI: 10.2105/AJPH.2021.306431

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   11.561


  10 in total

1.  To end the opioid crisis, we must address painful social disparities.

Authors:  Nora D Volkow
Journal:  Drug Alcohol Depend       Date:  2021-03-18       Impact factor: 4.492

2.  Structural Racism and the Opioid Overdose Epidemic: The Need for Antiracist Public Health Practice.

Authors:  Hillary V Kunins
Journal:  J Public Health Manag Pract       Date:  2020 May/Jun

3.  Racial Disparities in Overdose Prevention among People Who Inject Drugs.

Authors:  Lauren Dayton; Karin Tobin; Oluwaseun Falade-Nwulia; Melissa Davey-Rothwell; Alia Al-Tayyib; Haneefa Saleem; Carl Latkin
Journal:  J Urban Health       Date:  2020-12       Impact factor: 3.671

4.  Deaths: injuries, 2001.

Authors:  Robert N Anderson; Arialdi M Miniño; Lois A Fingerhut; Margaret Warner; Melissa A Heinen
Journal:  Natl Vital Stat Rep       Date:  2004-06-02

5.  African Americans now outpace whites in opioid-involved overdose deaths: a comparison of temporal trends from 1999 to 2018.

Authors:  Debra Furr-Holden; Adam J Milam; Ling Wang; Richard Sadler
Journal:  Addiction       Date:  2020-09-15       Impact factor: 6.526

6.  Association of Racial/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States.

Authors:  William C Goedel; Aaron Shapiro; Magdalena Cerdá; Jennifer W Tsai; Scott E Hadland; Brandon D L Marshall
Journal:  JAMA Netw Open       Date:  2020-04-01

7.  Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths - United States, 2013-2019.

Authors:  Christine L Mattson; Lauren J Tanz; Kelly Quinn; Mbabazi Kariisa; Priyam Patel; Nicole L Davis
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-02-12       Impact factor: 17.586

8.  Differences in Opioid Overdose Mortality Rates Among Middle-Aged Adults by Race/Ethnicity and Sex, 1999-2018.

Authors:  Rachel A Hoopsick; Gregory G Homish; Kenneth E Leonard
Journal:  Public Health Rep       Date:  2020-11-19       Impact factor: 2.792

9.  The HEALing (Helping to End Addiction Long-term SM) Communities Study: Protocol for a cluster randomized trial at the community level to reduce opioid overdose deaths through implementation of an integrated set of evidence-based practices.

Authors: 
Journal:  Drug Alcohol Depend       Date:  2020-10-17       Impact factor: 4.852

10.  Operationalizing and selecting outcome measures for the HEALing Communities Study.

Authors:  Svetla Slavova; Marc R LaRochelle; Elisabeth D Root; Daniel J Feaster; Jennifer Villani; Charles E Knott; Jeffery Talbert; Aimee Mack; Dushka Crane; Dana Bernson; Austin Booth; Sharon L Walsh
Journal:  Drug Alcohol Depend       Date:  2020-10-02       Impact factor: 4.852

  10 in total
  12 in total

1.  Placing Racial Equity at the Center of Substance Use Research: Lessons From the HEALing Communities Study.

Authors:  Avik Chatterjee; LaShawn Glasgow; Mackenzie Bullard; Mariah Sabir; Greer Hamilton; Deborah Chassler; Danelle J Stevens-Watkins; Dawn Goddard-Eckrich; Emma Rodgers; Joan Chaya; Sandra Rodriguez; Damara N Gutnick; Emmanuel A Oga; Pamela Salsberry; Linda Sprague Martinez
Journal:  Am J Public Health       Date:  2022-02       Impact factor: 9.308

2.  Eliminating the buprenorphine DEA X waiver is critical to promote health equity.

Authors:  Katie Fitzgerald Jones; Monica O'Reilly-Jacob; Mathew Tierney
Journal:  Nurs Outlook       Date:  2021-12-08       Impact factor: 3.250

3.  Design, Implementation, and Evolution of the Medicaid Outcomes Distributed Research Network (MODRN).

Authors:  Kara Zivin; Lindsay Allen; Andrew J Barnes; Stefanie Junker; Joo Yeon Kim; Lu Tang; Susan Kennedy; Katherine A Ahrens; Marguerite Burns; Sarah Clark; Evan Cole; Dushka Crane; David Idala; Paul Lanier; Shamis Mohamoud; Marian Jarlenski; Mary Joan McDuffie; Jeffery Talbert; Adam J Gordon; Julie M Donohue
Journal:  Med Care       Date:  2022-07-15       Impact factor: 3.178

4.  Effects of Medicaid expansion on alcohol and opioid treatment admissions in U.S. racial/ethnic groups.

Authors:  Nina Mulia; Camillia K Lui; Kara M K Bensley; Meenakshi S Subbaraman
Journal:  Drug Alcohol Depend       Date:  2021-12-24       Impact factor: 4.852

5.  Variations in national availability of waivered buprenorphine prescribers by racial and ethnic composition of zip codes.

Authors:  Katherine A Hirchak; Solmaz Amiri; Gordon Kordas; Oladunni Oluwoye; Abram J Lyons; Kelsey Bajet; Judith A Hahn; Michael G McDonell; Aimee N C Campbell; Kamilla Venner
Journal:  Subst Abuse Treat Prev Policy       Date:  2022-05-25

6.  "In their mind, they always felt less than": The role of peers in shifting stigma as a barrier to opioid use disorder treatment retention.

Authors:  Morgan S Anvari; Mary B Kleinman; Ebonie C Massey; Valerie D Bradley; Julia W Felton; Annabelle M Belcher; Jessica F Magidson
Journal:  J Subst Abuse Treat       Date:  2022-01-16

7.  If we build it, will they come? Perspectives on pharmacy-based naloxone among family and friends of people who use opioids: a mixed methods study.

Authors:  Susannah Slocum; Jenny E Ozga; Rebecca Joyce; Alexander Y Walley; Robin A Pollini
Journal:  BMC Public Health       Date:  2022-04-13       Impact factor: 3.295

8.  Frequency of the Dopamine Receptor D3 (rs6280) vs. Opioid Receptor µ1 (rs1799971) Polymorphic Risk Alleles in Patients with Opioid Use Disorder: A Preponderance of Dopaminergic Mechanisms?

Authors:  Marjorie C Gondré-Lewis; Igor Elman; Tanya Alim; Edwin Chapman; Beverlyn Settles-Reaves; Carine Galvao; Mark S Gold; David Baron; Shan Kazmi; Eliot Gardner; Ashim Gupta; Catherine Dennen; Kenneth Blum
Journal:  Biomedicines       Date:  2022-04-07

9.  Healthcare Utilization of Patients with Opioid Use Disorder in US Hospitals from 2016 to 2019: Focusing on Racial and Regional Variances.

Authors:  Sun Jung Kim; Mar Medina; Jongwha Chang
Journal:  Clin Drug Investig       Date:  2022-08-24       Impact factor: 3.580

10.  Hospitalizations for Alcohol and Opioid Use Disorders in Older Adults: Trends, Comorbidities, and Differences by Gender, Race, and Ethnicity.

Authors:  Andrea Acevedo; Ivette Rodriguez Borja; Tania M Alarcon Falconi; Nicole Carzo; Elena Naumova
Journal:  Subst Abuse       Date:  2022-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.